Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 31, 2023. (Total: 217454Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Colorectal Neoplasms and TOP1[original query]
Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 14 (6): 1788-96.
Hoskins Janelle M, Marcuello Eugenio, Altes Albert, Marsh Sharon, Maxwell Taylor, Van Booven Derek J, Paré Laia, Culverhouse Robert, McLeod Howard L, Baiget Montserr
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.
PloS one 2013 8 (4): e60613.
Smith David Hersi, Christensen Ib Jarle, Jensen Niels Frank, Markussen Bo, Rømer Maria Unni, Nygård Sune Boris, Müller Sven, Nielsen Hans Jørgen, Brünner Nils, Nielsen Kirsten Va
Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Molecular oncology 2015 Jun 9 (6): 1207-17.
Sønderstrup Ida Marie Heeholm, Nygård Sune Boris, Poulsen Tim Svenstrup, Linnemann Dorte, Stenvang Jan, Nielsen Hans Jørgen, Bartek Jiri, Brünner Nils, Nørgaard Peter, Riis Le
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.
Frontiers in pharmacology 2017 8 712.
Labriet Adrien, De Mattia Elena, Cecchin Erika, Lévesque Éric, Jonker Derek, Couture Félix, Buonadonna Angela, D'Andrea Mario, Villeneuve Lyne, Toffoli Giuseppe, Guillemette Chant
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
The pharmacogenomics journal 2019 Dec .
Reynolds Ian S, O'Connell Emer, Fichtner Michael, McNamara Deborah A, Kay Elaine W, Prehn Jochen H M, Furney Simon J, Burke John
Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy.
Frontiers in oncology 2020 4 10 466.
Cao Hua, Liu Xinyi, Chen Yixin, Yang Pan, Huang Tanxiao, Song Lele, Xu Ruili
TOP